DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Neurodiagnostics Market Analysis By Technology, By In Vitro Diagnostics, By Neuroinformatics And Segment Forecasts To 2024" report to their offering.
The global neurodiagnostics market was valued at 13.6 billion in 2015 and is expected to reach a value of USD 18.3 billion by 2024.
Key factors driving the market growth include increasing prevalence of neurological diseases due to demographic changes and growing awareness of their management. In addition, consistent technological modifications coupled with increased preference for novel diagnostic technologies will further fuel the market. The economic burden of neurological diseases is extremely high on society and governments with around 1 billion people suffering globally.
Biomarkers are an important part of in vitro diagnostics for neurological disorders as their development is targeted at the early disease diagnosis with information about nervous system. Although biomarkers are not commercially available in the market, their use is confined to clinical research settings.
Increased life expectancy has resulted in increased geriatric population across the globe. The prevalence of aging-related neurological diseases such as Alzheimer's disease and Parkinson's disease is on the rise. The diagnosis of these diseases includes neuroimaging, in vitro diagnosis, and neuroinformatics.
North America held the major market share of around 36% in the year 2015 and will retain its top position during the forecast period. On the other hand, Asia Pacific will exhibit highest CAGR of 4% over the forecast period.
- Agilent Technologies
- Alpha Omega Ltd.
- Doric Lenses, Inc.
- Fonar Corporation
- GE Healthcare
- Hitachi Medical Corporation
- Hologic, Inc.
- Mightex Systems
- NeuroNexus Technologies
- Neusoft Medical Systems Co., Ltd.
- Philips Healthcare
- Plexon, Inc.
- Roche Diagnostics
- Siemens Healthcare
- Toshiba Medical Systems Corporation
Key Topics Covered:
1 Methodology & Scope
2 Executive Summary
3 Market Summary
4 Market Variables, Trends& Scope
5 Market Categorization 1: Technology Estimates & Trend Analysis
6 Market Categorization 2: Regional Estimates & Trend Analysis, by Technology
7 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/995bbd/neurodiagnostics